glp 1 what does it mean GLP-1 receptor agonists GLP-1 for Diabetes vs GLP-1

At LCS Medical Spa, client safety and comfort remain our highest priorities

30, Sept

Clinical Trial Insights In SURMOUNT-1 and SURPASS trials, Mounjaro showed: Up to 22.5% body weight reduction in non-diabetic obese patients Greater HbA1c reductions vs Ozempic and insulin in diabetics Reference : Tirzepatide as Compared with Semaglutide for the Treatment of Obesity Reference : mounjaro.lilly.com/hcp/a1c-weight FDA approved Mounjaro for Type 2 Diabetes in 2022, and later for weight loss under the brand Zepbound in Nov 2023 (US)

only 9% of placebo-treated patients, achieving statistical significance ( P = 0.019)

Its real food that helps your body do what its already built to do

Serological changes can precede clinical symptoms by weeks